Increasing lipid peroxidation by vitamin E deficiency does not augment adriamycin-induced inhibition of hepatic drug metabolism

John E. Atkinson, Chandra C. Gairola, William C. Lubawy

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Adriamycin treatment in vivo or addition to incubation mixtures in vitro inhibits hepatic drug metabolism. It has been suggested that adriamycin-induced membrane lipid peroxidation may be a mechanism responsible for this activity in vitro. To determine if similar mechanisms operate in vivo, adriamycin inhibition of drug metabolism was compared in rats whose tissue lipid peroxidizability was altered by manipulating dietary levels of vitamin E. Weanling rats maintained on vitamin E deficient (0 ppm) or supplemented (10 or 100ppm) diets for 12 weeks were given either adriamycin, 5 mg/kg/week, or equal volumes of the saline vehicle for 3 weeks intraperitoneally. Vitamin E deficiency alone (0 ppm, saline pretreatment) produced a 37% increase in hepatic lipid peroxidation without any appreciable alteration in hepatic aniline hydroxylase, ethylmorphine N-demethylase or aryl hydrocarbon hydroxylase activities. Adriamycin pretreatment altered hepatic lipid peroxidizability over corresponding saline pretreated controls dependent on dietary vitamin E. No increase was seen in the 100 ppm group, while 44% and 500% increases occurred at 10 and 0 ppm vitamin E, respectively. Adriamycin pretreatment decreased drug-metabolizing enzyme activity by an average of 32% for aniline hydroxylase, 26% for ethylmorphine N-demethylase and 63% for aryl hydrocarbon hydroxylase. Statistically, decreases in drug metabolism were independent of dietary vitamin E and did not correlate with lipid peroxidizability. These data would suggest that in vivo adriamycin-induced depression of hepatic drug-metabolizing enzymes is not mediated by elevated lipid peroxidation.

Original languageEnglish
Pages (from-to)121-129
Number of pages9
JournalToxicology
Volume29
Issue number1-2
DOIs
StatePublished - Dec 1983

Fingerprint

Vitamin E Deficiency
Enzyme inhibition
Vitamin E
Metabolism
Doxorubicin
Lipid Peroxidation
Lipids
Liver
Pharmaceutical Preparations
Ethylmorphine-N-Demethylase
Aniline Hydroxylase
Aryl Hydrocarbon Hydroxylases
Rats
Enzyme activity
Enzymes
Membrane Lipids
Nutrition
Tissue
Diet

Keywords

  • Adriamycin
  • Aniline
  • Benzo[a]pyrene
  • Doxorubicin
  • Drug metabolism
  • Ethylmorphine
  • Lipid peroxidation
  • Rats
  • Vitamin E
  • Vitamin E deficiency
  • α-Tocopherol

Cite this

Atkinson, John E. ; Gairola, Chandra C. ; Lubawy, William C. / Increasing lipid peroxidation by vitamin E deficiency does not augment adriamycin-induced inhibition of hepatic drug metabolism. In: Toxicology. 1983 ; Vol. 29, No. 1-2. pp. 121-129.
@article{0768f8b514174924b0c618016bbfe263,
title = "Increasing lipid peroxidation by vitamin E deficiency does not augment adriamycin-induced inhibition of hepatic drug metabolism",
abstract = "Adriamycin treatment in vivo or addition to incubation mixtures in vitro inhibits hepatic drug metabolism. It has been suggested that adriamycin-induced membrane lipid peroxidation may be a mechanism responsible for this activity in vitro. To determine if similar mechanisms operate in vivo, adriamycin inhibition of drug metabolism was compared in rats whose tissue lipid peroxidizability was altered by manipulating dietary levels of vitamin E. Weanling rats maintained on vitamin E deficient (0 ppm) or supplemented (10 or 100ppm) diets for 12 weeks were given either adriamycin, 5 mg/kg/week, or equal volumes of the saline vehicle for 3 weeks intraperitoneally. Vitamin E deficiency alone (0 ppm, saline pretreatment) produced a 37{\%} increase in hepatic lipid peroxidation without any appreciable alteration in hepatic aniline hydroxylase, ethylmorphine N-demethylase or aryl hydrocarbon hydroxylase activities. Adriamycin pretreatment altered hepatic lipid peroxidizability over corresponding saline pretreated controls dependent on dietary vitamin E. No increase was seen in the 100 ppm group, while 44{\%} and 500{\%} increases occurred at 10 and 0 ppm vitamin E, respectively. Adriamycin pretreatment decreased drug-metabolizing enzyme activity by an average of 32{\%} for aniline hydroxylase, 26{\%} for ethylmorphine N-demethylase and 63{\%} for aryl hydrocarbon hydroxylase. Statistically, decreases in drug metabolism were independent of dietary vitamin E and did not correlate with lipid peroxidizability. These data would suggest that in vivo adriamycin-induced depression of hepatic drug-metabolizing enzymes is not mediated by elevated lipid peroxidation.",
keywords = "Adriamycin, Aniline, Benzo[a]pyrene, Doxorubicin, Drug metabolism, Ethylmorphine, Lipid peroxidation, Rats, Vitamin E, Vitamin E deficiency, α-Tocopherol",
author = "Atkinson, {John E.} and Gairola, {Chandra C.} and Lubawy, {William C.}",
year = "1983",
month = "12",
doi = "10.1016/0300-483X(83)90044-6",
language = "English",
volume = "29",
pages = "121--129",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

Increasing lipid peroxidation by vitamin E deficiency does not augment adriamycin-induced inhibition of hepatic drug metabolism. / Atkinson, John E.; Gairola, Chandra C.; Lubawy, William C.

In: Toxicology, Vol. 29, No. 1-2, 12.1983, p. 121-129.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Increasing lipid peroxidation by vitamin E deficiency does not augment adriamycin-induced inhibition of hepatic drug metabolism

AU - Atkinson, John E.

AU - Gairola, Chandra C.

AU - Lubawy, William C.

PY - 1983/12

Y1 - 1983/12

N2 - Adriamycin treatment in vivo or addition to incubation mixtures in vitro inhibits hepatic drug metabolism. It has been suggested that adriamycin-induced membrane lipid peroxidation may be a mechanism responsible for this activity in vitro. To determine if similar mechanisms operate in vivo, adriamycin inhibition of drug metabolism was compared in rats whose tissue lipid peroxidizability was altered by manipulating dietary levels of vitamin E. Weanling rats maintained on vitamin E deficient (0 ppm) or supplemented (10 or 100ppm) diets for 12 weeks were given either adriamycin, 5 mg/kg/week, or equal volumes of the saline vehicle for 3 weeks intraperitoneally. Vitamin E deficiency alone (0 ppm, saline pretreatment) produced a 37% increase in hepatic lipid peroxidation without any appreciable alteration in hepatic aniline hydroxylase, ethylmorphine N-demethylase or aryl hydrocarbon hydroxylase activities. Adriamycin pretreatment altered hepatic lipid peroxidizability over corresponding saline pretreated controls dependent on dietary vitamin E. No increase was seen in the 100 ppm group, while 44% and 500% increases occurred at 10 and 0 ppm vitamin E, respectively. Adriamycin pretreatment decreased drug-metabolizing enzyme activity by an average of 32% for aniline hydroxylase, 26% for ethylmorphine N-demethylase and 63% for aryl hydrocarbon hydroxylase. Statistically, decreases in drug metabolism were independent of dietary vitamin E and did not correlate with lipid peroxidizability. These data would suggest that in vivo adriamycin-induced depression of hepatic drug-metabolizing enzymes is not mediated by elevated lipid peroxidation.

AB - Adriamycin treatment in vivo or addition to incubation mixtures in vitro inhibits hepatic drug metabolism. It has been suggested that adriamycin-induced membrane lipid peroxidation may be a mechanism responsible for this activity in vitro. To determine if similar mechanisms operate in vivo, adriamycin inhibition of drug metabolism was compared in rats whose tissue lipid peroxidizability was altered by manipulating dietary levels of vitamin E. Weanling rats maintained on vitamin E deficient (0 ppm) or supplemented (10 or 100ppm) diets for 12 weeks were given either adriamycin, 5 mg/kg/week, or equal volumes of the saline vehicle for 3 weeks intraperitoneally. Vitamin E deficiency alone (0 ppm, saline pretreatment) produced a 37% increase in hepatic lipid peroxidation without any appreciable alteration in hepatic aniline hydroxylase, ethylmorphine N-demethylase or aryl hydrocarbon hydroxylase activities. Adriamycin pretreatment altered hepatic lipid peroxidizability over corresponding saline pretreated controls dependent on dietary vitamin E. No increase was seen in the 100 ppm group, while 44% and 500% increases occurred at 10 and 0 ppm vitamin E, respectively. Adriamycin pretreatment decreased drug-metabolizing enzyme activity by an average of 32% for aniline hydroxylase, 26% for ethylmorphine N-demethylase and 63% for aryl hydrocarbon hydroxylase. Statistically, decreases in drug metabolism were independent of dietary vitamin E and did not correlate with lipid peroxidizability. These data would suggest that in vivo adriamycin-induced depression of hepatic drug-metabolizing enzymes is not mediated by elevated lipid peroxidation.

KW - Adriamycin

KW - Aniline

KW - Benzo[a]pyrene

KW - Doxorubicin

KW - Drug metabolism

KW - Ethylmorphine

KW - Lipid peroxidation

KW - Rats

KW - Vitamin E

KW - Vitamin E deficiency

KW - α-Tocopherol

UR - http://www.scopus.com/inward/record.url?scp=0021053528&partnerID=8YFLogxK

U2 - 10.1016/0300-483X(83)90044-6

DO - 10.1016/0300-483X(83)90044-6

M3 - Article

C2 - 6658795

AN - SCOPUS:0021053528

VL - 29

SP - 121

EP - 129

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1-2

ER -